Safety
Vagus nerve stimulator side effects: what the research reports
Numbers from a systematic review of 51 studies, what each effect actually feels like, and the adjustments that reduce the common ones.
The short answer
Across 51 studies covering 1,322 people receiving transcutaneous vagus nerve stimulation, the most common side effect was skin irritation where the electrode sits, reported by 18.2 percent. Headache followed at 3.6 percent and cold-like symptoms at 1.7 percent. Serious events were rare and mostly not attributed to the stimulation.
Reviewers consistently describe the approach as well tolerated. That conclusion rests on mostly short research periods under supervision, which is worth holding in mind before reading it as a verdict on years of daily use at home.
What is reported, and how often
| Effect | How often | What people describe |
|---|---|---|
| Skin irritation where the electrode sits | 18.2 percent, 240 of 1,322 | Redness, itching or a rash under the contact point, usually fading within hours |
| Headache | 3.6 percent, 47 of 1,322 | Mild and short lived, most often reported after longer or higher intensity sessions |
| Cold-like symptoms | 1.7 percent, 23 of 1,322 | Reported as nasopharyngitis in the trials, and hard to attribute to the stimulation itself |
The figures come from a systematic review in Brain Stimulation covering 51 studies of transcutaneous stimulation. A later systematic review and meta-analysis in Scientific Reports, focused on auricular stimulation specifically, reaches the same broad conclusion about tolerability.
One thing the numbers make clear: this is a category where one effect dominates. Skin irritation is roughly five times more common than the next item on the list, and it is also the most fixable.
What reduces the common ones
These are drawn from what the manufacturers instruct in their own manuals and from the patterns in the reviewed studies. None of it is medical advice, and none of it replaces asking a clinician about your own situation.
Skin irritation. This is the most common effect by a wide margin and the most fixable. Apply the conductive gel or solution as instructed rather than sparingly, clean the contact area after each session, and move the placement slightly within the correct zone rather than using the exact same spot daily. Give irritated skin a day off. Manufacturers say not to use these devices on broken or irritated skin at all.
Headache after a session. Reported more with longer sessions and higher intensity. The usual approach is to reduce intensity to the lowest setting where you still feel the stimulation clearly, and to shorten the session before shortening the course.
Feeling wired rather than calm. Some users, particularly people with sensitised nervous systems, describe feeling activated or oversensitive rather than settled. What people try first is less: shorter sessions, fewer per week, lower intensity. If it persists, stop and speak to a clinician.
Ear discomfort with clip devices. Ear anatomy varies and clips do not fit everyone. Pain at the tragus is not something to push through. Reposition within the manufacturer’s guidance, and if it still hurts, that device is the wrong shape for your ear rather than a device you need to tolerate.
Dizziness or light headedness. Manufacturers instruct you to end the session if this happens. It is on the stop list rather than the adjust list.
When to stop rather than adjust
Most of the list above is about turning something down. These are the signals where the manufacturers say to end the session instead.
- Discomfort that does not fade after the session ends
- Dizziness, light headedness or feeling faint
- Any change in heart rhythm you can feel
- Skin that stays irritated between sessions
There is also a separate question of whether you should be using one of these devices at all. Implanted electronics, metal implants near the stimulation site, severe bradycardia and pregnancy all appear in manufacturer contraindications. Our safety and contraindications guide quotes each manufacturer directly.
What this data does not cover
The safety literature in this field is genuinely reassuring and genuinely narrow. Most participants were studied for weeks rather than years, under supervision, at parameters set by researchers rather than chosen by the user.
Consumer devices are used differently. Longer courses, self selected intensity, no supervision, and sometimes a placement the manual did not intend. None of that is represented in the 18.2 percent figure.
The reasonable reading is that short term tolerability is well established and long term home use is simply not studied yet. That is a gap in the evidence rather than a hidden risk, and it argues for the lowest intensity that does anything rather than the highest you can stand.
Sources
- Brain Stimulation, 2018 Safety and tolerability of transcutaneous vagus nerve stimulation in humans, a systematic review. 51 studies, 1,322 people receiving stimulation.
- Scientific Reports, 2022 Safety of transcutaneous auricular vagus nerve stimulation, a systematic review and meta-analysis.
Frequently asked questions
Across 51 studies and 1,322 people receiving transcutaneous stimulation, the most common effect was skin irritation where the electrode sits, at 18.2 percent, then headache at 3.6 percent and cold-like symptoms at 1.7 percent. Serious events were rare and mostly not attributed to the stimulation.